{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:20:11Z","timestamp":1746591611757,"version":"3.40.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Fibrin-specific fibrinolytics are preferred when they used in STEMI patients (pharmaco-invasive approach). However, streptokinase is still the most common used thrombolytic agent in Egypt because of its cheaper cost.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>266 STEMI patients were randomly assigned to undergo PPCI or pharmacoinvasive (using streptokinase). Primary end point (death, shock, congestive heart failure, or reinfarction up to 30 d) and secondary end point (ischemic stroke, intracranial hemorrhage, or nonintracranial bleeding) were followed for 30 days after reperfusion. In pharmaco-invasive arm, urgent coronary angiography was performed in case of failed reperfusion. Based on the reperfusion time from symptoms onset, patients in both arms were divided into; early (\u22643 hrs) and late reperfusion (&gt;3 hrs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>No statistical significant difference regarding left ventricular ejection fraction, end diastolic and end systolic diameter in both arms. Early PPCI (\u22643 hrs) had highest ejection fraction values (56.9\u2009\u00b1\u20097.5). Myocardial wall preservation was best achieved in early pharmaco-invasive (\u22643 hrs).There was no statistical significant difference in TIMI flow results between all subgroups (early and late of both arms) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.750). Suction devices and IV Eptifibatide were less frequently used in the pharmaco-invasive comparing to PPCI arm; (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.000 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.006) subsequently. No statistical significant difference regarding complication incidence in both arms (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.518). Radial access was more commonly used in the pharmaco-invasive arm (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.015).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Utilizing streptokinase in early re-perfused patients by PI approach (\u22643 hrs) seems safe and efficient when PPCI delay (&gt;120\u2009min from symptom onset) is the other option.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000250","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T05:40:40Z","timestamp":1608356440000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Pharmaco-invasive Approach Using Streptokinase Compared With Primary Percutaneous Coronary Angiography"],"prefix":"10.1097","volume":"20","author":[{"given":"El-Zahraa M.","family":"Sultan","sequence":"first","affiliation":[{"name":"Cardiology Department, Beni-Suef University Hospital, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Elberry","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Faculty of Medicine, Beni-Suef University Hospital, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Rabea","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham B.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Beni-Suef University Hospital, Beni-Suef, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ehj.2004.04.029","article-title":"Time is muscle in primary PCI: the strength of the evidence grows.","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40256-019-00327-7","article-title":"Pharmacoinvasive approach with streptokinase in low to intermediate risk ST-elevation myocardial infarction patients: insights from the Tamil Nadu-STEMI initiative.","volume":"19","author":"Kumbhani","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.106.638353","article-title":"Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.","volume":"114","author":"Pinto","year":"2006","journal-title":"Circulation"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"e003508","DOI":"10.1161\/CIRCINTERVENTIONS.115.003508","article-title":"Pharmacoinvasive strategy versus primary percutaneous coronary intervention in patients with ST-segment\u2013elevation myocardial infarction: a propensity score\u2013matched analysis.","volume":"9","author":"Sim","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"R7-20250506","first-page":"CD001560","article-title":"Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.","volume":"2","author":"Cucherat","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.114.009570","article-title":"ST\u2013segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: strategic reperfusion early after myocardial infarction (STREAM) 1-year mortality follow-up.","volume":"130","author":"Sinnaeve","year":"2014","journal-title":"Circulation"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/echo.14588","article-title":"Observational study of left ventricular global longitudinal strain in ST-segment elevation myocardial infarction patients with extended pharmaco-invasive strategy: a six months follow-up study.","volume":"37","author":"Manjunath","year":"2020","journal-title":"Echocardiography"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (radial versus femoral randomized investigation in ST-elevation acute coronary syndrome) study.","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/CIA.S218827","article-title":"The impact of advanced age on major cardiovascular events and mortality in patients with ST-elevation myocardial infarction undergoing a pharmaco-invasive strategy.","volume":"15","author":"Helber","year":"2020","journal-title":"Clin Interv Aging"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11239-006-5485-9","article-title":"Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).","volume":"21","author":"Ahmed","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2019.09.044","article-title":"Pharmacoinvasive strategy versus primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients\u2265 70 years of age.","volume":"125","author":"Auffret","year":"2020","journal-title":"Am J Cardiol"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5334\/aogh.2632","article-title":"Efficacy and safety of pharmacoinvasive strategy compared to primary percutaneous coronary intervention in the management of ST-segment elevation myocardial infarction: a prospective country-wide registry.","volume":"86","author":"Zubaid","year":"2020","journal-title":"Ann Glob Health"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1538-7836.2008.03195.x","article-title":"The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction.","volume":"7","author":"Van de Werf","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R17-20250506","first-page":"20761","article-title":"Prehospital facilitated intervention as a potential \u201csally port\u201d for the rescue of acute ST-segment elevation myocardial infarction: a meta-analysis.","volume":"9","author":"Yang","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/eurheartj\/ehr403","article-title":"Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers.","volume":"33","author":"Larson","year":"2012","journal-title":"Eur Heart J"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ehj.2017.04.001","article-title":"Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach.","volume":"70","author":"Sultan","year":"2018","journal-title":"Egyptian Heart J"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:03:15Z","timestamp":1746558195000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000250","relation":{},"ISSN":["1535-2811"],"issn-type":[{"type":"electronic","value":"1535-2811"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}